Variant report
Variant | rs569322447 |
---|---|
Chromosome Location | chr19:18496916-18496917 |
allele | A/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:18485800-18499000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr19:18491400-18497400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr19:18491600-18497400 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
4 | chr19:18491800-18497000 | Weak transcription | Lung | lung |
5 | chr19:18492000-18498800 | Weak transcription | Right Ventricle | heart |
6 | chr19:18493800-18497600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr19:18495200-18497000 | Enhancers | Fetal Intestine Large | intestine |
8 | chr19:18495600-18497000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr19:18495600-18497200 | Enhancers | Stomach Mucosa | stomach |
10 | chr19:18495800-18497000 | Enhancers | Liver | Liver |
11 | chr19:18495800-18497200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr19:18495800-18497400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
13 | chr19:18496200-18497000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr19:18496200-18497000 | Enhancers | GM12878-XiMat | blood |
15 | chr19:18496200-18497200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
16 | chr19:18496200-18497400 | Active TSS | Rectal Mucosa Donor 29 | rectum |
17 | chr19:18496400-18497000 | Enhancers | H1 Cell Line | embryonic stem cell |
18 | chr19:18496400-18497000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
19 | chr19:18496400-18497000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
20 | chr19:18496400-18497000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
21 | chr19:18496400-18497000 | Enhancers | Muscle Satellite Cultured Cells | -- |
22 | chr19:18496400-18497000 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
23 | chr19:18496400-18497000 | Enhancers | Placenta Amnion | Placenta Amnion |
24 | chr19:18496400-18497000 | Enhancers | NH-A | brain |
25 | chr19:18496400-18497000 | Enhancers | NHDF-Ad | bronchial |
26 | chr19:18496400-18497000 | Enhancers | NHLF | lung |
27 | chr19:18496400-18498000 | Bivalent Enhancer | Monocytes-CD14+_RO01746 | blood |
28 | chr19:18496400-18498600 | Flanking Active TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
29 | chr19:18496400-18499000 | Enhancers | Primary hematopoietic stem cells | blood |
30 | chr19:18496400-18499000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
31 | chr19:18496400-18499000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
32 | chr19:18496400-18499000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
33 | chr19:18496400-18499000 | Active TSS | Foreskin Melanocyte Primary Cells skin01 | Skin |
34 | chr19:18496600-18497000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
35 | chr19:18496600-18497000 | Bivalent Enhancer | Rectal Smooth Muscle | rectum |
36 | chr19:18496600-18497000 | Active TSS | HepG2 | liver |
37 | chr19:18496600-18497000 | Enhancers | HSMM | muscle |
38 | chr19:18496600-18497000 | Weak transcription | HSMMtube | muscle |
39 | chr19:18496600-18497000 | Enhancers | NHEK | skin |
40 | chr19:18496600-18497200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
41 | chr19:18496600-18497400 | Bivalent Enhancer | Primary Natural Killer cells fromperipheralblood | blood |
42 | chr19:18496600-18497800 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
43 | chr19:18496600-18497800 | Active TSS | Rectal Mucosa Donor 31 | rectum |
44 | chr19:18496600-18498200 | Bivalent Enhancer | Primary monocytes fromperipheralblood | blood |
45 | chr19:18496600-18498200 | Flanking Active TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
46 | chr19:18496800-18497000 | Flanking Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
47 | chr19:18496800-18497000 | Weak transcription | H9 Cell Line | embryonic stem cell |
48 | chr19:18496800-18497000 | Flanking Active TSS | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
49 | chr19:18496800-18497000 | Bivalent Enhancer | Primary B cells from peripheral blood | blood |
50 | chr19:18496800-18497000 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |